Standard Biotools Inc.
LAB· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Revenue | $28.62M | $27.61M | $17.48M | $12.95M |
| Net Income | -$15.24M | -$12.68M | -$4.05M | -$4.58M |
| EPS Diluted | -$0.53 |
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR
| -$0.45 |
| -$0.16 |
| -$0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.